Express News | WUXI BIO and Dohi Biotechnology have reached a research service collaboration with Aadi Bioscience for three innovative ADCs.

BreakingsDec 20 08:15

Yearly Review | The top ten repurchase kings of Hong Kong stocks in 2024 are announced! All Market repurchase total exceeds 250 billion Hong Kong dollars, with Tencent accounting for a "half of the market".

According to Wind data, as of December 17, 277 Hong Kong stocks have conducted buybacks this year, with a total buyback amount of 256.117 billion Hong Kong dollars, and 64 individual stocks have a cumulative buyback amount exceeding 0.1 billion Hong Kong dollars this year.

Futu NewsDec 18 18:30

Quick look at the Hong Kong market | All three major Indices closed higher, the Science and Technology Index rose nearly 2%; technology, Autos, and Biotechnology stocks climbed, with Li Auto rising over 5%, and Xiaomi Group and WUXI BIO rising nearly 3%.

Many Network Technology stocks are rising, XIAOMI-W is up 2.84%, Baidu Group-SW is up 1.74%; Semiconductor stocks are all rising, HG SEMI is up 7.64%, BEKE is down 2.78%; Autos stocks are climbing, LEAPMOTOR is up 6.42%, BRILLIANCE CHI is up 6.29%;

Futu NewsDec 18 16:22

Express News | The USA Biological Security Act was not included in the CR bill.

BreakingsDec 18 15:53

Quick look at the Hong Kong market | The Hong Kong stock market continues to decline in the afternoon, with all three major indices falling over 2%; The drops in the tech, Autos, and Mainland Real Estate sectors have widened, with SUNAC down over 8%, Xpen

Network Technology stocks fell, MEITUAN-W dropped 3.73%, NTES-S fell 2.90%; most Alcoholic Beverages stocks declined, GRACEWINE dropped 9.36%, TIBET WATER rose 7.69%; most semiconductor stocks declined, SHEEN TAI rose 5.82%, HG SEMI fell 5.00%;

Futu NewsDec 13 16:24

WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection

Leading Green CRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry SHANGHAI, Dec. 12, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio"

PR NewswireDec 12 16:30